Skip to main content
Log in

Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9α,11β-PGF2 and PGF

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The rank orders of potency of prostaglandin D2, prostaglandin F, 9α,11β-prostaglandin F2 and the stable thromboxane A2 mimetics U-46619 and ONO-11113 were determined in guinea-pig trachea and human bronchus in vitro. In both tissues the thromboxane mimetics were markedly more potent than the other prostanoids with EC50 values in the nanomolar range. The prostanoid antagonists BW-245C, EP-092 and GR-32191 attenuated the contractile responses to all of the prostanoid agonists and TXA2 mimetics tested in guinea-pig tracheal spirals, although agonist selectivity was seen. Contractile responses to methacholine in the guinea-pig trachea were unaffected by any of the antagonists employed. BW-245C antagonised the effects of all prostanoid agonists tested in human bronchial spirals, the pA2 values obtained were similar to those seen in the guinea-pig trachea when U-46619 and 9α,11β-PGF2 were employed as the agonists. However, significant differences were found between the two tissues when PGD2 and PGF. were tested against BW245C. EP-092 produced pA2 values against prostanoid agonists in the human bronchus similar to those seen in the guinea-pig trachea, as did GR-32191. It is concluded that whilst the contractile responses of guinea-pig and human airways smooth muscle to prostaglandin D2, and the other prostanoids are mediated predominantly via thromboxane (TP) receptors, it can be inferred that other receptor populations may contribute to the contractile response. The presence of these minor subpopulations may account for the agonist selectivity seen both within and between tissues from different species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH (1985) Competitive antagonism at thromboxane receptors in human platelets. Br J Pharmacol 84:595–607

    Google Scholar 

  • Bacon KB, Hoult JRS, Osborne DJ, Robinson C (1987) Metabolism of prostaglandin D2 to 9α,11β-PGF2 & subsequent transformation in rat, rabbit and guinea-pig. Br J Pharmacol 91:32P

  • Beasley CRW, Hovell CJ, Mani R, Robinson C, Holgate ST (1987a) The comparative vascular effects of histamine, prostaglandin D2 and its metabolite 9α,11β-PGF2 in human skin. Br J Clin Pharmacol 23:605-606P (Abstract)

    Google Scholar 

  • Beasley CRW, Robinson C, Featherstone RL, Varley JG, Hardy CC, Church MK, Holgate ST (1987b) 9-α,11β-Prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest 79:978–983

    Google Scholar 

  • Coleman RA, Humphrey PPA, Kennedy I, Levy GP, Lumley P (1981) Comparison of the actions of U-46619, a prostaglandin H2 analogue with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73:773–778 P

    Google Scholar 

  • Coleman RA, Kennedy I, Sheldrick RLG (1985) AH6809, a prostanoid EP1 receptor blocking drug. Br J Pharmacol 85:273

    Google Scholar 

  • Coleman RA, Sheldrick RLG (1989) Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br J Pharmacol 96:688–692

    Google Scholar 

  • Farmer JB, Farrar DG, Wilson J (1974) Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220. Br J Pharmacol 52:559–565

    Google Scholar 

  • Flower RJ, Harvey EA, Kingston WP (1976) Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol 56:229–233

    Google Scholar 

  • Fujioka M, Nagao T, Kuriyama H (1986) Actions of the novel thromboxane A2 antagonists ONO-1270 and ONO-3708 on smooth muscle cells of the guinea-pig basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 334:468–474

    Google Scholar 

  • Gardiner PJ (1986) Characterisation of prostanoid relaxant/inhibitory receptors using a highly selective agonist, TR4979. Br J Pharmacol 87:45–56

    Google Scholar 

  • Gardiner PJ, Collier HOJ (1980) Specific receptors for prostaglandins in the airways. Prostaglandins 19:819–841

    Google Scholar 

  • Gardiner PJ, Jones RL, McKenniff M, Norman P, Rodger I (1987) Prostanoid contractile receptors on guinea-pig and human air-ways. Br J Pharmacol 91:363P

    Google Scholar 

  • Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD (1989) The classification of DP-receptors in platelets and vasculature using BW-868C, a novel, selective and potent competitive antagonist. Br J Pharmacol 96:291–300

    Google Scholar 

  • Godard P, Chaintreuil J, Damon M, Coupe M, Flandre O, Crastes De Paulet A, Michel FB (1982) Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J Allergy Clin Immunol 70:88–93

    Google Scholar 

  • Goetzl EJ, Weller PF, Valone FH (1976) Biochemical and functional bases of the regulatory protective roles of the human eosinophil. Advances Inflammation Res 1:157–167

    Google Scholar 

  • Gorman RR, Shebuski RJ, Aiken JW, Bundy GL (1981) Analysis of the biological activity of azo-prostanoids in human platelets. Fed Proc 40:1997–2000

    Google Scholar 

  • Hamid-Bloomfield S, Whittle BJR (1986) Prostaglandin D2 interacts at thromboxane receptor sites on guinea-pig platelets. Br J Pharmacol 88:931–936

    Google Scholar 

  • Hardy CC, Holgate ST, Robinson C (1986) Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F following inhalation of prostaglandin D2 in man. Br J Pharmacol 87:563–568

    Google Scholar 

  • Holgate ST, Burns GB, Robinson C, Church MK (1984) Anaphylactic and calcium dependent generation of prostaglandin D2 (PGD2), thromboxane B2 and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 133:2138–2144

    Google Scholar 

  • Jones RL, Peesapati V, Wilson NH (1982) Antagonism of thromboxane-sensitive systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea. Br J Pharmacol 76:423–438

    Google Scholar 

  • Katsura M, Miyamoto T, Hamanaka N, Kondo K, Terada T, Ohgaki Y, Kawasaka A, Tsuboshima M (1983) In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylaminopinane derivatives). Adv Prostaglandin Thromboxane Leukotriene Res 11:351–357

    Google Scholar 

  • Kawahara Y, Yamanishi J, Furuta Y, Kaibuchi K, Takai Y, Fukuzaki H (1983) Elevation of cytoplasmic free calcium concentration by a stable thromboxane A2 analogue in human platelets. Biochem Biophys Res Commun 117:663–669

    Google Scholar 

  • Kenakin TP (1984) The relative contributions of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br J Pharmacol 81:131–134

    Google Scholar 

  • Kennedy I, Coleman RA, Humphrey PPA, Levy GP, Lumley P (1982) Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 24:667–689

    Google Scholar 

  • Leighton MJ (1982) Quantitative assessment of the pre- and post-synaptic alpha adrenoceptor agonist potency of amitriptyline. J Pharmacol Exp Ther 220:299–304

    Google Scholar 

  • Lewis RA, Soler NA, Diamond PT, Austen KF, Oates JA, Roberts LJ (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129:1627–1631

    Google Scholar 

  • Liston TE, Roberts LJ (1985a) Transformation of prostaglandin D2 to 9α,11β-(15S)-trihydroxy-prosta-(5Z,13E)-dien-1-oic acid (9α,11 β-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci USA 82:6030–6034

    Google Scholar 

  • Liston TE, Roberts LJ (1985b) Metabolic fate of radiolabelled prostaglandin D2 in a normal human male volunteer. J Biol Chem 260:13172–13180

    Google Scholar 

  • Lumley P, Humphrey PPA, White BP (1988) GR-32191, a novel thromboxane receptor blocking drug; effects upon platelets and vascular and airways smooth muscle. Br J Pharmacol 93:43P

    Google Scholar 

  • McKenniff M, Gardiner PJ, Norman P, Rodger IW (1987) Is there a novel contractile prostanoid receptor in human large airways. Br J Pharmacol 93:56P

    Google Scholar 

  • Morley J (1983) Mediators and cyclic nucleotides in asthma. In: Clark TJH, Godfrey S (eds) Asthma. Chapman and Hall, London, pp 285–300

    Google Scholar 

  • Narumiya S, Toda N (1985) Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. Br J Pharmacol 85:367–375

    Google Scholar 

  • Richards IM, Oostveen JA, Griffin RL, Bunting S (1987) Pulmonary pharmacology of synthetic thromboxane A2. Adv Prostaglandin Thromboxane Leukotriene Res 17B:1067–1072

    Google Scholar 

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature, New Biol 231:232–235

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to: R. L. Featherstone at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Featherstone, R., Robinson, C., Holgate, S. et al. Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9α,11β-PGF2 and PGF . Naunyn-Schmiedeberg's Arch Pharmacol 341, 439–443 (1990). https://doi.org/10.1007/BF00176337

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00176337

Key words

Navigation